fig1

Scoping review of digital pathology for neoadjuvant rectal cancer response

Figure 1. PRISMA flow diagram of study selection. Searches of PubMed, Embase, and the Cochrane Library identified 707 records (with 0 records identified from registers). After removal of 98 duplicates, 609 records underwent title and abstract screening, and 589 were excluded. All 20 reports sought for retrieval were retrieved and assessed in full text for eligibility. Nine reports were excluded because of wrong publication type (n = 1), abstract-only publication (n = 2), assessment of overall survival after adjuvant chemotherapy (n = 1), exclusion of patients receiving neoadjuvant therapy (n = 1), metastatic cancer (n = 1), immunotherapy (n = 1), or a multimodal model without separately reported pathology results (n = 2). Eleven publications (11 studies) were included in the review. PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses; n: number of records.